Beware of the mid-August “pro-Medicare” mailer from the American Action Network pretending to encourage your congressman to pass HR 5122. Sponsored by the super-wealthy pharmaceutical industry, HR 5122 would bar the implementation of a proposed Medicare cost-reduction plan.
Medicare spent $22 billion on Part B prescription drugs in 2015, double the amount of 2007. This increase is used by Republican perpetrators to argue with twisted logic for Medicare cuts. The Center for Medicare and Medicaid Services proposes to reduce a doctors’ fee from 4.3 percent to 2.5 percent and to add a flat $16.80 per drug per patient, thus, seriously cutting back Big Pharma’s gigantic Medicare profits.
Consistent with value-based care and the removal of perverse incentives to deliver more expensive care than needed, this CMS proposal makes progress on reducing the rate of increase in prescription drug spending. Rather than telling Republican Devin Nunes to vote “yes” on HR 5122 (as if he was against it, ha!), I urge a “no” vote.
Mike Starry, Fresno